Perspective Therapeutics, Inc. — Director's Dealing 2009

Jun 10, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2009-06-08

Reporting Person: Hunt Jonathan Robert (CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-06-08	Stock option (right to buy)	$0.26	A	100000	Acquired	2019-06-08	Common stock (100000)	Direct

Footnotes

F1: 33,333 vest on 6/8/10, 33,333 vest on 6/8/11, and 33,334 vest on 6/8/12.